Diagnostic Code 8106 · 38 CFR §4.124a
Huntington disease is a progressive, fatal, autosomal dominant neurodegenerative disorder caused by expansion of a CAG trinucleotide repeat in the huntingtin gene on chromosome 4. The disease typically begins between the ages of 30 and 50 with progressive choreiform movements (uncontrollable, dance-like writhing of limbs and trunk), progressive cognitive decline (executive dysfunction, dementia), psychiatric symptoms (depression, anxiety, irritability, psychosis), and ultimately complete loss of function over 15 to 20 years from symptom onset. Because the disease is genetic and produces symptoms decades after birth, the question of service connection is technical: Huntington disease per se is not caused by service, but aggravation of the premorbid condition is recognized when service stressors clearly accelerated symptom onset or progression. Some veterans first develop symptoms during active duty when the genetic onset coincides with service. The 38 CFR §4.124a framework rates DC 8106 with a 30% protected minimum and higher tiers reflecting the inexorable progression of the disease.
| Rating | Criteria |
|---|---|
| 30% | Minimum schedular evaluation for any confirmed Huntington disease diagnosis with mild current symptoms, regardless of current functional level. The minimum reflects the progressive, irreversible nature of the disease. |
| 60% | Moderate disease — definite chorea producing functional limitation, mild-to-moderate cognitive decline (executive dysfunction, slowed processing), psychiatric symptoms requiring treatment, with measurable impairment in daily activity. |
| 80% | Severe disease — pronounced chorea limiting ambulation, moderate-to-severe cognitive impairment (dementia), significant psychiatric symptoms, substantial functional impairment requiring assistance with activities of daily living. |
| 100% | Total impairment — late-stage disease with severe dementia, immobility, dysphagia requiring feeding modifications or gastrostomy, complete dependence for activities of daily living, and requirement for aid and attendance. Special Monthly Compensation under 38 USC 1114 applies based on the specific functional losses. |
Genetic testing confirming CAG repeat expansion in the huntingtin gene is the definitive diagnostic test and is essential for current claims. Neurology consult documenting the characteristic motor, cognitive, and psychiatric features supports the rating. MRI of the brain showing caudate atrophy supports the diagnosis. Neuropsychological testing characterizes the cognitive decline. Records of psychiatric treatment, antichorea medications (tetrabenazine, deutetrabenazine), and functional assessments establish the disease state. Service medical records documenting symptom onset during active duty or aggravation of premorbid symptoms support service connection through direct nexus or aggravation theory.
Huntington disease itself is caused by an inherited genetic mutation, so direct causation by service is not the typical pathway. The recognized pathways are: (1) aggravation — service stressors accelerated symptom onset or progression beyond what would have occurred naturally, supported by medical literature and a nexus opinion; (2) in-service onset — symptoms first appeared during active duty, supporting service connection of the manifestations even though the genetic mutation predated service. Both pathways require careful documentation and typically benefit from a representative or attorney experienced with genetic-disease claims.
Genetic testing confirms the diagnosis but does not by itself establish service connection. The relevance of testing is that it makes the diagnosis definitive, eliminates differential diagnoses, and supports the rating decision. The Genetic Information Nondiscrimination Act (GINA) and VA policies have specific frameworks for handling genetic information in claims. Veterans are generally encouraged to undergo testing for diagnostic clarity, with the understanding that the result is part of the medical record relevant to the claim.
Huntington disease is autosomal dominant, meaning each child of an affected veteran has a 50% chance of inheriting the mutation. The VA disability rating itself does not extend benefits to family members beyond the standard DIC framework for surviving spouses of veterans rated 100% for ten years or more. Genetic counseling for children is appropriate but is not part of the VA disability framework; it is typically pursued through civilian healthcare.